The emerging therapy of the medication represents a major breakthrough in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide096206.canariblogs.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-57040056